Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 191,762 Werewolf Therapeutics, Inc. shares (Form 4)

Traded May 21 to May 26, 2026 · Filed May 26, 2026

From May 21 to May 26, 2026, Luke Evnin (Director) sold 191,762 Werewolf Therapeutics, Inc. shares at an average US$0.45 for US$86,560 under a trading plan, leaving 763,685 shares. Filed May 26, 2026 (Form 4).

Sold
191,762 shares
Price
US$0.45 average (US$0.42 to US$0.47)
Value
US$86,560
Holding after
763,685 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 21, 2026Common StockSale36,387US$0.42919,060Indirect
May 22, 2026Common StockSale87,425US$0.45831,635Indirect
May 26, 2026Common StockSale67,950US$0.47763,685Indirect

Source

View original at SEC

Related